(redirected from Loss of heterozygosity)
Also found in: Medical, Encyclopedia, Wikipedia.
LOHLoss of Heterozygosity
LOHLadies Of Harley
LOHLate-Onset Hypogonadism
LOHLiturgy of the Hours (religious practice)
LOHLocal Overload Handler
LOHLebanon Opera House (Lebanon, NH)
LOHLine Overhead
LOHLight Observation Helicopter
LOHLegion of Honor
LOHLarge Object Heap
LOHLabor and Overhead
LOHLoop of Henle (kidney nephron)
LOHLay on Hands (Paladin ability; Everquest game)
LOHLegend of Heroes (gaming)
LOHLady of the House
LOHLots of Hugs
LOHLoss Of Hire (shipping)
LOHLegion of Havok (gaming)
LOHLive Open House (virtual real estate network)
LOHLine Off Hook
References in periodicals archive ?
8) However, these findings contrast with more recent results from molecular studies using DNA sequencing and loss of heterozygosity analysis.
At the molecular level in primary GBMs, loss of heterozygosity (LOH) at 10q is the most frequent genetic alteration in primary GBMs observed in 69% patients, followed by EGFR amplification (34%), tumour protein 53 (TP53) mutations (31%), p16INK4a deletion (31%), and phosphatase and tensin homolog (PTEN) mutation (24%).
Here, we compare loss of heterozygosity (LOH) in clear cell RCC (ccRCC) between the ones with and without PIS.
3] Nonstandard abbreviations: miRNA, microRNA; CLL, chronic lymphocytic leukemia; LOH, loss of heterozygosity.
Maternal cell contamination and loss of heterozygosity is also identifiable using SNP arrays.
Borsatti noted that researchers can easily combine OneSeq with Agilent's free-of-charge SureCall software to integrate data analysis of copy number variations, single nucleotide polymorphisms, indels, and loss of heterozygosity.
Given that the gradual accumulation of these new mutations--Mullets ratchet--is less of a contributor for asexual decline than the Lynch team's findings on simple loss of heterozygosity and exposure of preexisting, deleterious alleles, evolutionary biologists now will need to look at the persistence of other asexual genomes in a new way, Lynch believes.
Recent molecular studies showing loss of heterozygosity of certain tumor suppressor genes in many odontogenic keratocysts have supported this opinion.
The polymorphic markers are also used to analyze Loss of Heterozygosity (LOH) of a specific locus.
Interestingly, the cancer specimen showed no loss of heterozygosity (LOH), in which one side of the DNA's chromosome becomes inactive because of a mutation.
NF1-associated GISTs almost uniformly do not exhibit gain-of-function activation of KIT or PDGFA (pathogenesis is suggested to be from the loss of heterozygosity of the NF1 gene) and are not likely to respond to imatinib.